A summary of published research, not medical advice. See the Disclaimer.
Studies: every indexed trial and review on this topic, scored
Morning light exposure is bright light soon after waking, from outdoor daylight or a light box of about 2,500 to 10,000 lux.
Best-supported effect: Light shifting the body clock earlier, measured by the timing of the evening melatonin rise. Probably helps (moderate evidence).
Most-cited weak claim: A few minutes of morning sunlight improves sleep and energy in healthy adults. Unknown (not tested).
How we grade evidence · Last reviewed: October 2026
What you need to know
Light shifted the body clock earlier, measured by the timing of the evening melatonin rise, with moderate evidence. The popular claim that a few minutes of morning sunlight improves sleep and energy in healthy adults has not been tested. Bright light reduced depressive symptoms in seasonal and in nonseasonal depression, with weak evidence. In nonseasonal depression, hypomania was more common with bright light, mostly when light was added to drugs or sleep deprivation. One case report describes damage to the centre of the retina in a person on clomipramine during light therapy, and there are no eye safety data for people with existing eye disease. Seasonal depression trials used light boxes or visors of at least 1,000 lux, and a clinical review describes 2,500 to 10,000 lux for 30 to 60 minutes at the same time each day.
| Effect | Verdict | What was measured | Studied in |
|---|---|---|---|
| Shifts the body clock earlier | Probably helps (moderate evidence) Melatonin timing shifted in small samples, including a camping study |
Lab marker | Healthy adults on a summer camping trip; lab studies |
In the camping study, living under natural light only, with no electric light, moved the internal clock earlier so it lined up with sunrise and sunset. Later sleepers shifted the most [5]. A systematic review found that evening, night and morning light all shifted melatonin timing, and that many studies had 10 or fewer participants [6]. The melatonin rise is how the body clock is measured, so the lab-marker rule does not apply to this claim. Probably helps (moderate evidence): downgraded because the samples were small. The result does not show an effect on sleep or health.
| Claim | Verdict | What was measured | Studied in |
|---|---|---|---|
| Fewer depressive symptoms in seasonal depression | May help (weak evidence) Pooled 19 controlled trials, people knew they got light and rated their own mood, bias concerns |
Self-reported | Adults diagnosed with seasonal affective disorder |
| Fewer depressive symptoms in nonseasonal depression | May help (weak evidence) 11 controlled trials with 858 participants, light added to treatment, people knew what they got, short |
Self-reported | Adults with major depression, often on antidepressants |
| A few minutes of morning sunlight improves sleep and energy | Unknown (not tested) Claim stretched from lab melatonin studies and one camping study |
Self-reported | No trials of this protocol |
| Fewer depressive symptoms in bipolar depression, added to medication | Unknown (very weak evidence) 4 controlled trials with 190 participants, more people improved, full recovery no different |
Self-reported | Adults with bipolar depression, 4 small RCTs |
| Fewer seasonal depression episodes when started before winter | Unknown (very weak evidence) One trial of 46 participants, too small to show a difference |
Self-reported | Adults with a history of seasonal depression, one small trial |
Seasonal depression: a 2005 meta-analysis of RCTs included only 13% of the studies it screened. The effect size was about 0.84 for bright light (8 studies) and 0.73 for dawn simulation (5 studies) [1]. A 2020 meta-analysis of 19 RCTs found a smaller benefit over placebo and rated the trials at moderate-to-high risk of bias [2]. May help (weak evidence): light can't be blinded, mood is self-rated, and the trials had moderate-to-high risk of bias.
Nonseasonal depression: a 2025 meta-analysis of 11 RCTs with 858 participants linked bright light added to treatment with higher response and remission rates than control conditions [3]. A 2020 meta-analysis of 23 RCTs pointed the same way, with large differences between trials [4]. In the 2005 analysis, light alone had an effect size of about 0.53 [1]. May help (weak evidence): the same blinding problem, and the 2020 analysis rated its evidence low quality. Many trials lasted only a few weeks.
The brief-sunlight claim is extrapolated from lab studies of how light shifts melatonin timing and from one small camping study. No trial has tested short outdoor exposure against sleep or energy outcomes in healthy adults [5][6].
Bipolar depression: a meta-analysis of 4 RCTs with 190 participants reported higher response rates when light was added to medication, with no significant difference in remission [7]. Prevention: a Cochrane review of light started before winter found one trial with 46 participants. It was too small to show a difference, and the review rated the certainty very low [8]. Both claims are unknown (very weak evidence).
No study has tested light at any time of day against long-term outcomes such as weight, heart health or lifespan.
Shown in humans
Shown only in animals or cells
Theory only
| Side effect | Verdict | How often vs placebo | Source | Studied in |
|---|---|---|---|---|
| Switching into mania or hypomania in bipolar depression, light added to medication | May not increase it (weak evidence) Switching into mania about 1% in both groups, 190 people, few events |
1.1% vs 1.2% (4 RCTs, 190 people); rare in a 44-person trial | [7][19] | 190 people |
| Serious adverse effects in bipolar depression | May not increase it (weak evidence) 4 controlled trials in bipolar depression, no rates reported |
Not reported | [7] | 190 participants |
| Hypomania in nonseasonal depression, mostly light added to drugs or sleep deprivation | May happen (weak evidence) Cochrane review, 4.91 times the risk, mostly light added to other treatment, poorly reported data |
Risk ratio 4.91 (95% CI 1.66–14.46; number needed to harm 8) | [17] | |
| Hypomania in seasonal depression | Unknown (very weak evidence) One case among 30 patients, no comparison group |
1 of 30, uncontrolled series | [18] | 30 patients |
| Eye discomfort or vision complaints | Unknown (very weak evidence) Complaint rates vary widely across studies, no placebo comparison |
0% to 45% of participants across studies; no placebo comparison | [18][20] | |
| Eye damage in healthy people not on medication | Unknown (very weak evidence) Formal review of 43 articles, no rates reported |
Not reported | [20] | Healthy people |
| Sleep disturbance with evening light | Unknown (very weak evidence) Patient series with no comparison group, 5 of 8 using evening light |
5 of 8 using evening light, uncontrolled series | [18] | |
| Agitation or autonomic overactivation | Unknown (very weak evidence) Patient series with no comparison group, 3 of 30 affected |
3 of 30, uncontrolled series | [18][21] | |
| Any adverse event in nonseasonal depression | May not increase it (weak evidence) One 122-person controlled trial, few differences from fake treatment, rates not reported |
Not reported; few significant differences from sham | [22] | Patients with nonseasonal major depressive disorder |
The two hypomania results come from different populations. The nonseasonal trials mostly added light to drug treatment, sleep deprivation or both, and many did not report adverse effects systematically [17]. The bipolar trials added light to medication and found switching rare in both groups [7][19]. Both are graded Limited: the nonseasonal data were poorly reported, and the bipolar data come from 190 people with very few events. Side effects were poorly recorded. The prevention trial gave no information on adverse events [8]. In the uncontrolled series, side effects were mild and eased with time or less light, and no one stopped treatment [18].
This lists what studies and labels report. A pharmacist or prescriber can say whether it applies to a specific person.
This lists what studies and labels report. A pharmacist or prescriber can say whether it applies to a specific person.
| Combined with | What happened | Verdict | Source | Studied in |
|---|---|---|---|---|
| Fluoxetine | In an 8-week RCT of 122 adults, light plus fluoxetine was well tolerated, with few significant differences in adverse events between groups | May not increase it (weak evidence) 8-week controlled trial of 122 adults, well tolerated in combination |
[22] | 122 adults |
| Medication for bipolar depression | Adding light to medication gave switching rates into mania of about 1% in both groups | May not increase it (weak evidence) Switching into mania about 1% with or without light, few events |
[7] | 190 participants |
| Clomipramine | One case report of maculopathy during light therapy | Unknown (very weak evidence) Report of a single patient with retina damage on clomipramine |
[20] | |
| Lithium | In rats, light made lithium-related retinal changes worse, depending on light intensity | Unknown (very weak evidence) Only rat data, retina changes tracked light intensity |
[23] | Rats |
These are the amounts used in the studies. They are not recommendations.
The seasonal depression trials compared light boxes or visors of at least 1,000 lux with dim light or sham devices [2]. The prevention trial used 2,500 lux light visors [8]. A clinical review describes 2,500 to 10,000 lux for 30 to 60 minutes at the same time each day as typically effective [9]. Some trials used dawn simulation, a light that brightens gradually before waking [1]. In the nonseasonal trials, follow-up ranged from under 4 weeks to longer [3]. The circadian study used natural outdoor light, with no electric light, on a summer camping trip [5]. No trial has tested a fixed amount of outdoor morning sunlight.